Berlin - Delayed Quote EUR
Protalix BioTherapeutics Inc (PBDA.BE)
At close: October 25 at 8:08 AM GMT+2
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
84,434.0000
55,787.0000
73,665.0000
67,934.0000
--
Total Liabilities Net Minority Interest
50,865.0000
66,427.0000
79,701.0000
94,971.0000
--
Total Equity Gross Minority Interest
33,569.0000
-10,640.0000
-6,036.0000
-27,037.0000
--
Total Capitalization
33,569.0000
17,547.0000
21,851.0000
-27,037.0000
--
Common Stock Equity
33,569.0000
-10,640.0000
-6,036.0000
-27,037.0000
--
Capital Lease Obligations
6,030.0000
5,287.0000
5,583.0000
5,887.0000
--
Net Tangible Assets
33,569.0000
-10,640.0000
-6,036.0000
-27,037.0000
--
Working Capital
24,402.0000
12,451.0000
28,490.0000
-30,751.0000
--
Invested Capital
53,820.0000
17,547.0000
21,851.0000
31,476.0000
--
Tangible Book Value
33,569.0000
-10,640.0000
-6,036.0000
-27,037.0000
--
Total Debt
26,281.0000
33,474.0000
33,470.0000
64,400.0000
--
Net Debt
--
11,076.0000
--
40,248.0000
37,466.0000
Share Issued
72,952.1240
53,790.1670
45,556.6470
34,765.2800
--
Ordinary Shares Number
72,952.1240
53,790.1670
45,556.6470
34,765.2800
--
12/31/2019 - 6/11/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade